MORPHINE SULFATE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded a direct order to DMS PHARMACEUTICAL GROUP INC under contract SPE2DX25D9900 for the provision of MORPHINE SULFATE INJECTION, identified by NSN 6505014830274 and PR 7017476142. The award, issued on July 13, 2026, carries a total value of $42.99 and is part of a federal procurement initiative managed through the DIBBS system. The contract is designated as an award notice with no specific set-aside type applied and is sourced directly by the Department of Defense through its DLA office, with no assigned NAICS code or detailed place of performance information provided. The sole line item represents a critical pharmaceutical supply, indicating a minimal but essential replenishment for military or defense medical operations. The point of contact details and delivery location remain unspecified in the public data.
General Info
Agency
Contract Value
$42.99NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
